期刊论文详细信息
| Perspectives in Clinical Research | |
| Drug lag and key regulatory barriers in the emerging markets | |
| 关键词: Drug lag; BRIC countries; N-11 countries; Emerging Markets; Marketing authorisation; Regulatory barriers; | |
| DOI : | |
| 来源: DOAJ | |
【 授权许可】
Unknown